Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Cytokine. 2019 Aug;120:85-87. doi: 10.1016/j.cyto.2019.04.015. Epub 2019 Apr 28.

PMID:
31035172
2.

Under phosphate starvation conditions, Fe and Al trigger accumulation of the transcription factor STOP1 in the nucleus of Arabidopsis root cells.

Godon C, Mercier C, Wang X, David P, Richaud P, Nussaume L, Liu D, Desnos T.

Plant J. 2019 Apr 29. doi: 10.1111/tpj.14374. [Epub ahead of print]

PMID:
31034704
3.

FLT3 ligand plasma levels in acute myeloid leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Haematologica. 2019 Jun;104(6):e240-e243. doi: 10.3324/haematol.2018.209460. Epub 2019 Jan 10. No abstract available.

4.

On the Operational Aspects of Measuring Nanoparticle Sizes.

Teulon JM, Godon C, Chantalat L, Moriscot C, Cambedouzou J, Odorico M, Ravaux J, Podor R, Gerdil A, Habert A, Herlin-Boime N, Chen SW, Pellequer JL.

Nanomaterials (Basel). 2018 Dec 23;9(1). pii: E18. doi: 10.3390/nano9010018.

5.

p53 regulates CD46 expression and measles virus infection in myeloma cells.

Lok A, Descamps G, Tessoulin B, Chiron D, Eveillard M, Godon C, Le Bris Y, Vabret A, Bellanger C, Maillet L, Barillé-Nion S, Gregoire M, Fonteneau JF, Le Gouill S, Moreau P, Tangy F, Amiot M, Moreau-Aubry A, Pellat-Deceunynck C.

Blood Adv. 2018 Dec 11;2(23):3492-3505. doi: 10.1182/bloodadvances.2018025106.

6.

A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.

Boutault R, Peterlin P, Boubaya M, Sockel K, Chevallier P, Garnier A, Guillaume T, Le Bourgeois A, Debord C, Godon C, Le Bris Y, Theisen O, Kroschinsky F, Moreau P, Béné MC, Platzbecker U, Eveillard M.

Br J Haematol. 2018 Dec;183(5):736-746. doi: 10.1111/bjh.15626. Epub 2018 Nov 8.

PMID:
30406952
7.

Two Tabersonine 6,7-Epoxidases Initiate Lochnericine-Derived Alkaloid Biosynthesis in Catharanthus roseus.

Carqueijeiro I, Brown S, Chung K, Dang TT, Walia M, Besseau S, Dugé de Bernonville T, Oudin A, Lanoue A, Billet K, Munsch T, Koudounas K, Melin C, Godon C, Razafimandimby B, de Craene JO, Glévarec G, Marc J, Giglioli-Guivarc'h N, Clastre M, St-Pierre B, Papon N, Andrade RB, O'Connor SE, Courdavault V.

Plant Physiol. 2018 Aug;177(4):1473-1486. doi: 10.1104/pp.18.00549. Epub 2018 Jun 22.

PMID:
29934299
8.

Transcriptional profiling of Scedosporium apiospermum enzymatic antioxidant gene battery unravels the involvement of thioredoxin reductases against chemical and phagocytic cells oxidative stress.

Staerck C, Tabiasco J, Godon C, Delneste Y, Bouchara JP, Fleury MJJ.

Med Mycol. 2019 Apr 1;57(3):363-373. doi: 10.1093/mmy/myy033.

PMID:
29889264
9.

CD200 expression in flow cytometry helps to distinguish mantle cell lymphoma from other CD5-positive B-cell neoplasms.

Debord C, Robillard N, Theisen O, Gastinne T, Godmer P, Graveleau J, Le Gouill S, Luycx O, Tiab M, Loirat M, Lestang E, Wuillème S, Godon C, Eveillard M, Béné MC.

Hematol Oncol. 2018 Apr 15. doi: 10.1002/hon.2511. [Epub ahead of print] No abstract available.

PMID:
29656538
10.

Impact of Infection Status and Cyclosporine on Voriconazole Pharmacokinetics in an Experimental Model of Cerebral Scedosporiosis.

Lelièvre B, Briet M, Godon C, Legras P, Riou J, Vandeputte P, Diquet B, Bouchara JP.

J Pharmacol Exp Ther. 2018 May;365(2):408-412. doi: 10.1124/jpet.117.245449. Epub 2018 Feb 28.

PMID:
29491040
11.

Varying susceptibility of clinical and environmental Scedosporium isolates to chemical oxidative stress in conidial germination.

Staerck C, Godon C, Bouchara JP, Fleury MJJ.

Arch Microbiol. 2018 Apr;200(3):517-523. doi: 10.1007/s00203-018-1491-5. Epub 2018 Feb 20.

PMID:
29464281
12.

The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations.

Vivien R, Saïagh S, Lemarre P, Chabaud V, Jesson B, Godon C, Jarry U, Guillaume T, Chevallier P, Vié H, Clémenceau B.

Cytotherapy. 2018 Mar;20(3):436-452. doi: 10.1016/j.jcyt.2017.12.002. Epub 2018 Feb 1.

PMID:
29396255
13.

Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.

Lodé L, Ménard A, Flet L, Richebourg S, Loirat M, Eveillard M, Le Bris Y, Godon C, Theisen O, Gagez AL, Cartron G, Commes-Maerten T, Villemagne B, Luycx O, Godmer P, Pellat-Deceunynck C, Soussi T, Béné MC, Delaunay J, Peterlin P.

Haematologica. 2018 Apr;103(4):e143-e146. doi: 10.3324/haematol.2017.181404. Epub 2017 Dec 21. No abstract available.

14.

"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.

Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, Le Garff-Tavernier M, Bougacha N, Struski S, Bidet A, Laharanne E, Barin C, Veronese L, Prié N, Eclache V, Gaillard B, Michaux L, Lefebvre C, Gaillard JB, Terré C, Penther D, Bastard C, Nadal N, Fert-Ferrer S, Auger N, Godon C, Sutton L, Tournilhac O, Susin SA, Nguyen-Khac F; GroupeFrancophone de Cytogénétique Hématologique(GFCH) and the French Innovative Leukemia Organization (FILO) group.

Am J Hematol. 2018 Mar;93(3):375-382. doi: 10.1002/ajh.24990. Epub 2017 Dec 18.

15.

A standardized toolkit for genetic engineering of CTG clade yeasts.

Defosse TA, Courdavault V, Coste AT, Clastre M, de Bernonville TD, Godon C, Vandeputte P, Lanoue A, Touzé A, Linder T, Droby S, Rosa CA, Sanglard D, d'Enfert C, Bouchara JP, Giglioli-Guivarc'h N, Papon N.

J Microbiol Methods. 2018 Jan;144:152-156. doi: 10.1016/j.mimet.2017.11.015. Epub 2017 Nov 16.

PMID:
29155237
16.

Scedosporium boydii CatA1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis.

Mina S, Staerck C, Marot A, Godon C, Calenda A, Bouchara JP, Fleury MJJ.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):282-287. doi: 10.1016/j.diagmicrobio.2017.08.013. Epub 2017 Aug 26.

PMID:
28974395
17.

Low phosphate activates STOP1-ALMT1 to rapidly inhibit root cell elongation.

Balzergue C, Dartevelle T, Godon C, Laugier E, Meisrimler C, Teulon JM, Creff A, Bissler M, Brouchoud C, Hagège A, Müller J, Chiarenza S, Javot H, Becuwe-Linka N, David P, Péret B, Delannoy E, Thibaud MC, Armengaud J, Abel S, Pellequer JL, Nussaume L, Desnos T.

Nat Commun. 2017 May 15;8:15300. doi: 10.1038/ncomms15300.

18.

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?

Lestang E, Peterlin P, Le Bris Y, Dubruille V, Delaunay J, Godon C, Theisen O, Blin N, Mahe B, Gastinne T, Garnier A, Touzeau C, Voldoire M, Bene MC, Le Gouill S, Milpied N, Mohty M, Moreau P, Guillaume T, Chevallier P.

Eur J Haematol. 2017 Jul;99(1):60-69. doi: 10.1111/ejh.12891. Epub 2017 May 5.

PMID:
28370306
19.

Conditions to minimize soft single biomolecule deformation when imaging with atomic force microscopy.

Godon C, Teulon JM, Odorico M, Basset C, Meillan M, Vellutini L, Chen SW, Pellequer JL.

J Struct Biol. 2017 Mar;197(3):322-329. doi: 10.1016/j.jsb.2016.12.011. Epub 2016 Dec 23.

PMID:
28017791
20.

Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex.

Matray O, Mouhajir A, Giraud S, Godon C, Gargala G, Labbé F, Rougeron A, Ballet JJ, Zouhair R, Bouchara JP, Favennec L.

Med Mycol. 2016 May;54(4):409-19. doi: 10.1093/mmy/myv080. Epub 2015 Oct 19.

PMID:
26486722
21.

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.

Kervoëlen C, Ménoret E, Gomez-Bougie P, Bataille R, Godon C, Marionneau-Lambot S, Moreau P, Pellat-Deceunynck C, Amiot M.

Oncotarget. 2015 Sep 29;6(29):26922-34. doi: 10.18632/oncotarget.4616.

22.

Atomic force microscope, molecular imaging, and analysis.

Chen SW, Teulon JM, Godon C, Pellequer JL.

J Mol Recognit. 2016 Jan;29(1):51-5. doi: 10.1002/jmr.2491. Epub 2015 Jul 30.

PMID:
26224520
23.

The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.

Eveillard M, Delaunay J, Richebourg S, Lodé L, Garand R, Wuillème S, Duhoux F, Antoine-Poirel H, Godon C, Béné MC.

Haematologica. 2015 Mar;100(3):e114-5. doi: 10.3324/haematol.2014.121079. No abstract available.

24.

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.

Gomez-Bougie P, Halliez M, Maïga S, Godon C, Kervoëlen C, Pellat-Deceunynck C, Moreau P, Amiot M.

Cancer Biol Ther. 2015;16(1):60-5. doi: 10.4161/15384047.2014.986997.

25.

PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance.

Tessoulin B, Descamps G, Moreau P, Maïga S, Lodé L, Godon C, Marionneau-Lambot S, Oullier T, Le Gouill S, Amiot M, Pellat-Deceunynck C.

Blood. 2014 Sep 4;124(10):1626-36. doi: 10.1182/blood-2014-01-548800. Epub 2014 Jul 8.

26.

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.

Surget S, Descamps G, Brosseau C, Normant V, Maïga S, Gomez-Bougie P, Gouy-Colin N, Godon C, Béné MC, Moreau P, Le Gouill S, Amiot M, Pellat-Deceunynck C.

BMC Cancer. 2014 Jun 14;14:437. doi: 10.1186/1471-2407-14-437.

27.

Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease.

Lodé L, Moreau P, Ménard A, Godon C, Touzeau C, Amiot M, Le Gouill S, Béné MC, Pellat-Deceunynck C.

Blood Cancer J. 2013 Nov 22;3:e163. doi: 10.1038/bcj.2013.60. No abstract available.

28.

Subcellular localization and interaction network of the mRNA decay activator Pat1 upon UV stress.

Bahassou-Benamri R, Davin AH, Gaillard JC, Alonso B, Odorico M, Pible O, Armengaud J, Godon C.

Yeast. 2013 Sep;30(9):353-63. doi: 10.1002/yea.2968. Epub 2013 Aug 13.

29.

Experimental models of disseminated scedosporiosis with cerebral involvement.

Lelièvre B, Legras P, Godon C, Franconi F, Saint-André JP, Bouchara JP, Diquet B.

J Pharmacol Exp Ther. 2013 May;345(2):198-205. doi: 10.1124/jpet.112.201541. Epub 2013 Feb 20.

PMID:
23426955
30.

Eukaryotic GPN-loop GTPases paralogs use a dimeric assembly reminiscent of archeal GPN.

Alonso B, Beraud C, Meguellati S, Chen SW, Pellequer JL, Armengaud J, Godon C.

Cell Cycle. 2013 Feb 1;12(3):463-72. doi: 10.4161/cc.23367. Epub 2013 Jan 16.

31.

Generation of DNA single-strand displacement by compromised nucleotide excision repair.

Godon C, Mourgues S, Nonnekens J, Mourcet A, Coin F, Vermeulen W, Mari PO, Giglia-Mari G.

EMBO J. 2012 Aug 29;31(17):3550-63. doi: 10.1038/emboj.2012.193. Epub 2012 Aug 3.

32.

Kinetics of endogenous mouse FEN1 in base excision repair.

Kleppa L, Mari PO, Larsen E, Lien GF, Godon C, Theil AF, Nesse GJ, Wiksen H, Vermeulen W, Giglia-Mari G, Klungland A.

Nucleic Acids Res. 2012 Oct;40(18):9044-59. doi: 10.1093/nar/gks673. Epub 2012 Jul 18.

33.

A role for GPN-loop GTPase yGPN1 in sister chromatid cohesion.

Alonso B, Chaussinand G, Armengaud J, Godon C.

Cell Cycle. 2011 Jun 1;10(11):1828-37. Epub 2011 Jun 1.

PMID:
21532343
34.

PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.

Godon C, Cordelières FP, Biard D, Giocanti N, Mégnin-Chanet F, Hall J, Favaudon V.

Nucleic Acids Res. 2008 Aug;36(13):4454-64. doi: 10.1093/nar/gkn403. Epub 2008 Jul 4.

35.
36.

Quantitation of p53 nuclear relocation in response to stress using a yeast functional assay: effects of irradiation and modulation by heavy metal ions.

Godon C, Coullet S, Baus B, Alonso B, Davin AH, Delcuze Y, Marchetti C, Hainaut P, Kazmaier M, Quemeneur E.

Oncogene. 2005 Sep 22;24(42):6459-64.

PMID:
16007197
37.

Oriented carbon nanostructures containing nitrogen obtained by ion beam assisted deposition.

Paredez P, Figueroa CA, Zagonel LF, Reichert FR, Ribeiro CR, Point S, Godon C, Minea TM, Alvarez F.

J Nanosci Nanotechnol. 2005 Feb;5(2):188-91.

PMID:
15853135
38.

A novel strategy for creating recombinant infectious RNA virus genomes.

Fernandez-Delmond I, Pierrugues O, de Wispelaere M, Guilbaud L, Gaubert S, Divéki Z, Godon C, Tepfer M, Jacquemond M.

J Virol Methods. 2004 Nov;121(2):247-57.

PMID:
15381363
39.

Large deletions 5' to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia.

Godon C, Proffitt J, Dastugue N, Lafage-Pochitaloff M, Mozziconacci MJ, Talmant P, Hackbarth M, Bataille R, Avet-Loiseau H.

Leukemia. 2002 Sep;16(9):1752-4.

40.

[Influence of corneal refractive surgery on the lacrymal film].

Pisella PJ, Godon C, Auzerie O, Baudouin C.

J Fr Ophtalmol. 2002 Apr;25(4):416-22. Review. French.

41.

Fertile hypomorphic ARGONAUTE (ago1) mutants impaired in post-transcriptional gene silencing and virus resistance.

Morel JB, Godon C, Mourrain P, Béclin C, Boutet S, Feuerbach F, Proux F, Vaucheret H.

Plant Cell. 2002 Mar;14(3):629-39.

42.

Ionising radiation induces the expression of PARP-1 and PARP-2 genes in Arabidopsis.

Doucet-Chabeaud G, Godon C, Brutesco C, de Murcia G, Kazmaier M.

Mol Genet Genomics. 2001 Aug;265(6):954-63.

PMID:
11523787
43.

Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.

Godon C, Talmant P, Garand R, Accart F, Bataille R, Avet-Loiseau H.

Genes Chromosomes Cancer. 2000 Dec;29(4):350-2.

PMID:
11066080
44.

Molecular cloning and developmental expression of AtGR1, a new growth-related Arabidopsis gene strongly induced by ionizing radiation.

Deveaux Y, Alonso B, Pierrugues O, Godon C, Kazmaier M.

Radiat Res. 2000 Oct;154(4):355-64.

PMID:
11023598
45.

Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance.

Mourrain P, Béclin C, Elmayan T, Feuerbach F, Godon C, Morel JB, Jouette D, Lacombe AM, Nikic S, Picault N, Rémoué K, Sanial M, Vo TA, Vaucheret H.

Cell. 2000 May 26;101(5):533-42.

46.
47.

Amplification of the 11q23 region in acute myeloid leukemia.

Avet-Loiseau H, Godon C, Li JY, Daviet A, Mellerin MP, Talmant P, Harousseau JL, Bataille R.

Genes Chromosomes Cancer. 1999 Oct;26(2):166-70.

PMID:
10469455
48.

P53 deletion is not a frequent event in multiple myeloma.

Avet-Loiseau H, Li JY, Godon C, Morineau N, Daviet A, Harousseau JL, Facon T, Bataille R.

Br J Haematol. 1999 Sep;106(3):717-9.

PMID:
10468863
49.

Yap1 and Skn7 control two specialized oxidative stress response regulons in yeast.

Lee J, Godon C, Lagniel G, Spector D, Garin J, Labarre J, Toledano MB.

J Biol Chem. 1999 Jun 4;274(23):16040-6.

50.

Transgene-induced gene silencing in plants.

Vaucheret H, Béclin C, Elmayan T, Feuerbach F, Godon C, Morel JB, Mourrain P, Palauqui JC, Vernhettes S.

Plant J. 1998 Dec;16(6):651-9. Review. No abstract available.

Supplemental Content

Support Center